Food and Drug Administration

The Food and Drug Administration (FDA) is a federal agency responsible for protecting public health by regulating human and veterinary drugs, biological products, medical devices, food safety, cosmetics, and tobacco products. Recent news highlights the FDA's involvement in several controversial areas. The agency is considering easing restrictions on unproven peptide drugs, a move driven by Health and Human Services Secretary Robert F. Kennedy Jr., despite concerns from former FDA officials. The FDA is also facing pressure to expedite the review of psychedelic drugs like ibogaine for potential therapeutic uses, spurred by an executive order. Concerns about kratom poisonings, potentially linked to synthetic derivatives, are also under scrutiny. Furthermore, the FDA approved a generic medication for a rare brain disease but found little evidence it would help many people with autism. The agency is also monitoring potential risks associated with weight-loss drugs like Wegovy, which a study linked to a higher risk of sudden sight loss compared to Ozempic. These developments underscore the FDA's critical role in balancing innovation, access, and safety within the healthcare landscape.